Larvol Delta - Safety-Tolerability-Pharmacokinetic-and-Pharmacodynamic-Study-of-Oral-ASN51-in-Healthy-Subjects-and-Subjects-With-Alzheimer39s-Disease

ASN51 - Asceneuron

http://clinicaltrials.gov/ct2/show/NCT04759365

Jun 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next